Gilead Sciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 5 | -$1.56 | -$1.44 | -$1.49 |
| Q2 2024 | 5 | $1.61 | $1.61 | $1.61 |
| Q3 2024 | 8 | $1.50 | $1.56 | $1.53 |
| Q4 2024 | 14 | $1.18 | $2.07 | $1.71 |
| Q1 2025 | 6 | $1.70 | $1.81 | $1.75 |
| Q2 2025 | 5 | $1.75 | $1.90 | $1.82 |
| Q3 2025 | 5 | $1.97 | $2.15 | $2.05 |
| Q4 2025 | 5 | $1.99 | $2.17 | $2.07 |
Gilead Sciences, Inc. Earnings Date And Information
Gilead Sciences, Inc. last posted its earnings results on Wednesday, November 6th, 2024. The company reported $2.02 earnings per share for the quarter, topping analysts' consensus estimates of $1.53 by $0.49. The company had revenue of 7.55 B for the quarter and had revenue of 27.12 B for the year. Gilead Sciences, Inc. has generated $5 earnings per share over the last year ($4.5 diluted earnings per share) and currently has a price-to-earnings ratio of 881.51. Gilead Sciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 4th, 2025 based on prior year's report dates.
Gilead Sciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | $1.00 | $7.02 B | $7.55 B | ||
| 08/08/2024 | Q2 2024 | $1.61 | $1.29 | -0.32 | $6.70 B | $6.95 B |
| 05/08/2024 | Q1 2024 | -$3.34 | $6.69 B | |||
| 02/23/2024 | Q4 2023 | $1.15 | $7.12 B | |||
| 11/07/2023 | Q3 2023 | $1.91 | $1.75 | -0.16 | $6.81 B | $7.05 B |
| 08/04/2023 | Q2 2023 | $0.84 | $6.45 B | $6.60 B | ||
| 05/03/2023 | Q1 2023 | $0.81 | $6.35 B | |||
| 02/22/2023 | Q4 2022 | $1.31 | $7.39 B | |||
| 11/02/2022 | Q3 2022 | $1.43 | $6.13 B | $7.04 B | ||
| 08/08/2022 | Q2 2022 | $0.91 | $5.86 B | $6.26 B | ||
| 05/04/2022 | Q1 2022 | $0.01 | $6.59 B | |||
| 02/23/2022 | Q4 2021 | $0.30 | $7.24 B | |||
| 11/03/2021 | Q3 2021 | $2.06 | $6.29 B | $7.42 B | ||
| 08/05/2021 | Q2 2021 | $1.21 | $6.08 B | $6.22 B | ||
| 05/06/2021 | Q1 2021 | $1.38 | $6.42 B | |||
| 02/25/2021 | Q4 2020 | $1.24 | $7.42 B | |||
| 11/03/2020 | Q3 2020 | $0.29 | $6.29 B | $6.58 B | ||
| 08/06/2020 | Q2 2020 | -$2.66 | $5.29 B | $5.14 B | ||
| 05/05/2020 | Q1 2020 | $1.23 | $5.55 B | |||
| 02/24/2020 | Q4 2019 | $2.13 | $5.88 B |
Gilead Sciences, Inc. Earnings: Frequently Asked Questions
-
When is Gilead Sciences, Inc.'s earnings date?
Gilead Sciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 4th, 2025 based off last year's report dates.
-
Did Gilead Sciences, Inc. beat their earnings estimates last quarter?
In the previous quarter, Gilead Sciences, Inc. (:GILD) reported $2.02 earnings per share (EPS) to beat the analysts' consensus estimate of $1.53 by $0.49.
-
How can I listen to Gilead Sciences, Inc.'s earnings conference call?
The conference call for Gilead Sciences, Inc.'s latest earnings report can be listened to online.
-
How can I read Gilead Sciences, Inc.'s conference call transcript?
The conference call transcript for Gilead Sciences, Inc.'s latest earnings report can be read online.
-
How much revenue does Gilead Sciences, Inc. generate each year?
Gilead Sciences, Inc. (:GILD) has a recorded annual revenue of $27.12 B.
-
How much profit does Gilead Sciences, Inc. generate each year?
Gilead Sciences, Inc. (:GILD) has a recorded net income of $27.12 B. Gilead Sciences, Inc. has generated $4.54 earnings per share over the last four quarters.
-
What is Gilead Sciences, Inc.'s price-to-earnings ratio?
Gilead Sciences, Inc. (:GILD) has a price-to-earnings ratio of 881.51 and price/earnings-to-growth ratio is -9.99.
